Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AEGR-733 plus Atorvastatin in Moderate Hypercholesterolemia
NCT00690443Phase 2Completed
- Sponsor
- Aegerion Pharmaceuticals
- Start
- May 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lomitapide in hypercholesterolemia (2 arms), sponsored by Aegerion Pharmaceuticals. Primary endpoint: Percent Change in LDL-C After 8 Weeks of Therapy. Started May 2008; status: completed.
02
Drugs
lomitapide
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00690443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00690443.